CNS Pharmaceuticals, Inc. (CNSP)
5.75
-0.19
(-3.20%)
USD |
NASDAQ |
Sep 09, 16:00
5.75
0.00 (0.00%)
After-Hours: 17:45
CNS Pharmaceuticals Total Liabilities (Quarterly) : 3.738M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.738M |
| March 31, 2026 | 4.582M |
| December 31, 2025 | 4.101M |
| September 30, 2025 | 1.959M |
| June 30, 2025 | 1.383M |
| March 31, 2025 | 2.779M |
| December 31, 2024 | 2.524M |
| September 30, 2024 | 4.057M |
| June 30, 2024 | 6.763M |
| March 31, 2024 | 6.091M |
| December 31, 2023 | 6.133M |
| September 30, 2023 | 4.069M |
| June 30, 2023 | 3.997M |
| March 31, 2023 | 3.923M |
| December 31, 2022 | 4.920M |
| September 30, 2022 | 1.244M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.9239M |
| March 31, 2022 | 1.069M |
| December 31, 2021 | 2.594M |
| September 30, 2021 | 2.407M |
| June 30, 2021 | 1.831M |
| March 31, 2021 | 1.902M |
| December 31, 2020 | 1.905M |
| September 30, 2020 | 0.5108M |
| June 30, 2020 | 0.2612M |
| March 31, 2020 | 0.336M |
| December 31, 2019 | 0.311M |
| September 30, 2019 | 1.398M |
| June 30, 2019 | 1.264M |
| March 31, 2019 | 1.269M |
| December 31, 2018 | 1.233M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.94M |
| Shareholders Equity (Quarterly) | 18.20M |
| Current Ratio | 5.845 |
| Net Debt Paydown Yield | 0.60% |